Integration of the cancer cell secretome and transcriptome reveals potential noninvasive diagnostic markers for bladder cancer.
Yi-Ting ChenWei-Ju TuZong-Han YeChih-Ching WuShir-Hwa UengKai-Jie YuChien-Lun ChenPei-Hua PengJau-Song YuYing-Hsu ChangPublished in: Proteomics. Clinical applications (2024)
Collectively, our findings suggest TNPO2 as a potential noninvasive tumor-stage or grade discriminator for BLCA management.
Keyphrases